What is the current pre-market price of IGPH.SW stock?

IGPH.SW stock is trading pre-market at **CHF0.0015** on 27 Feb 2026 with volume at **2,033,000**, well above the average of **193,941** shares, indicating a short-term liquidity spike.

What grade and recommendation does Meyka AI give IGPH.SW?

Meyka AI rates IGPH.SW at **62.62 out of 100 (Grade B)** with a **HOLD** suggestion. The grade reflects sector comparison, key metrics, growth outlook, and analyst signals; it is informational only.

What is the Meyka AI forecast for IGPH.SW stock?

Meyka AI's forecast model projects **CHF0.00500** within 12 months, versus the current **CHF0.00150**, implying an estimated **+233.33%** upside. Forecasts are model-based projections and not guarantees.

What are the main risks for IGEA Pharma (IGPH.SW)?

Primary risks include low cash per share, negative working capital, operating losses, and volatile liquidity. Small company scale and thin trading depth increase execution and market risk.

CH Stocks

CHF0.0015 pre-market Feb 2026: IGPH.SW IGEA Pharma (SIX) most active, volume watch

ByHuzaifa Zahoor February 27, 2026

IGPH.SW stock opened pre-market at CHF0.0015 on 27 Feb 2026, making IGEA Pharma (IGPH.SW) the most active name on SIX by volume. Trading shows 2,033,000 shares versus an average of 193,941, sending a +10.48 relative volume signal. The intraday range is CHF0.0015–0.0020 after a -25.00% move from the prior close. We review why liquidity spiked, how fundamentals read against the sector, and what model forecasts imply for traders and longer-term investors.